Dr.BariatricHTX said:DerekSJ_a1c said: ...but the FDA says semaglutide...
Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.
A narrower follow-up, since the general answer is now clear:
How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?
DanielChem_CHI said:Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…
This is where I part company with the consensus forming above. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDanielChem_CHI said:Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.